We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+1.02%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.06B
AUM Growth
-$1.38M
Cap. Flow
+$20.5M
Cap. Flow %
1.94%
Top 10 Hldgs %
7.1%
Holding
774
New
159
Increased
222
Reduced
220
Closed
120

Top Buys

Rank Stock Value
1
TXG icon
10x Genomics
TXG
+$5.67M
2
SOFI icon
SoFi Technologies
SOFI
+$5.22M
3
TRU icon
TransUnion
TRU
+$4.01M
4
EXPE icon
Expedia Group
EXPE
+$3.93M
5
CNMD icon
CONMED
CNMD
+$3.78M

Top Sells

Rank Stock Value
1
RACE icon
Ferrari
RACE
+$7.81M
2
SWK icon
Stanley Black & Decker
SWK
+$5.62M
3
KMX icon
CarMax
KMX
+$4.41M
4
SG icon
Sweetgreen
SG
+$4.23M
5
MU icon
Micron Technology
MU
+$4.08M

Sector Composition

Rank Sector Weight
1 Technology 20.53%
2 Healthcare 19.51%
3 Industrials 14.23%
4 Consumer Discretionary 11.24%
5 Financials 10.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVBF icon
576
CVB Financial
CVBF
$3.97B
$256K 0.02%
14,870
-21,684
-59% -$361K
MX icon
577
Magnachip Semiconductor
MX
$126M
$256K 0.02%
52,471
-5,048
-9% -$25.4K
PLMR icon
578
Palomar
PLMR
$3.73B
$255K 0.02%
3,145
-1
-0% -$81
UWMC icon
579
UWM Holdings
UWMC
$624M
$255K 0.02%
36,808
+600
+2% +$4.12K
THRD
580
DELISTED
Third Harmonic Bio
THRD
$254K 0.02%
19,503
PRME icon
581
Prime Medicine
PRME
$544M
$254K 0.02%
+49,325
New +$299K
MGPI icon
582
MGP Ingredients
MGPI
$384M
$253K 0.02%
3,394
-1,402
-29% -$109K
ITRN icon
583
Ituran Location and Control
ITRN
$1.09B
$245K 0.02%
9,954
-4
-0% -$106
TYRA icon
584
Tyra Biosciences
TYRA
$1.85B
$245K 0.02%
15,306
+3,132
+26% +$53.9K
STLA icon
585
Stellantis
STLA
$16.5B
$244K 0.02%
12,302
SRCE icon
586
1st Source
SRCE
$2.09B
$242K 0.02%
+4,521
New +$229K
FITB
587
Fifth Third Bancorp
FITB
$51.7B
$242K 0.02%
6,641
+41
+0.6% +$1.5K
IMAX icon
588
IMAX
IMAX
$2.47B
$238K 0.02%
14,182
-19,245
-58% -$318K
MCY icon
589
Mercury Insurance
MCY
$6.01B
$238K 0.02%
+4,472
New +$242K
L icon
590
Loews
L
$24.4B
$235K 0.02%
+3,140
New +$238K
STEP icon
591
StepStone Group
STEP
$3.65B
$234K 0.02%
+5,100
New +$200K
TIPT icon
592
Tiptree Inc
TIPT
$678M
$231K 0.02%
14,018
+2,394
+21% +$40K
JRVR icon
593
James River Group Holdings
JRVR
$217M
$229K 0.02%
29,562
+16,604
+128% +$136K
NOA
594
North American Construction
NOA
$376M
$227K 0.02%
+11,784
New +$245K
MC icon
595
Moelis & Co
MC
$5.04B
$227K 0.02%
3,989
-24,342
-86% -$1.32M
VTS icon
596
Vitesse Energy
VTS
$636M
$225K 0.02%
9,478
-10,510
-53% -$250K
ARMK icon
597
Aramark
ARMK
$15.2B
$222K 0.02%
6,518
-447
-6% -$14.5K
TMCI icon
598
Treace Medical Concepts
TMCI
$265M
$218K 0.02%
+32,714
New +$264K
PFC
599
DELISTED
Premier Financial Corp. Common Stock
PFC
$216K 0.02%
10,543
+52
+0.5% +$1.03K
DDOG icon
600
Datadog
DDOG
$89.7B
$208K 0.02%
+1,600
New +$194K

Similar funds

PDT Partners's Q2 2024 Portfolio in Review

As of Q2 2024, PDT Partners held 774 positions worth $1.06B, down 0.13% from $1.06B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.

PDT Partners's Q2 2024 filing shows 159 new, 222 increased, 220 reduced and 120 closed positions. Its largest new stake was SoFi Technologies: 740,850 shares worth $4.9M. The largest sale was Ferrari, an estimated $7.81M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Industrials.

  • PDT Partners's largest Q2 2024 buy was SoFi Technologies: 740,850 shares worth $4.9M.
  • PDT Partners added most to 10x Genomics in Q2 2024, an estimated $5.67M increase.
  • PDT Partners's biggest Q2 2024 reduction was Ferrari, cutting an estimated $7.81M.
  • PDT Partners fully exited CarMax in Q2 2024, selling an estimated $4.41M.
  • PDT Partners's ten largest holdings make up 7.1% of its $1.06B portfolio in Q2 2024.
  • PDT Partners opened 159 new positions and closed 120 in Q2 2024.
  • PDT Partners's portfolio value fell 0.13% quarter-over-quarter to $1.06B.

Based on PDT Partners's 13F filing for Q2 2024, filed 15 Aug 2024.